Page last updated: 2024-08-22

Brilliant Blue and Vascular Injuries

Brilliant Blue has been researched along with Vascular Injuries in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brophy, C; Cheung-Flynn, J; Hocking, KM; Komalavilas, P; Li, FD; Luo, W	1

Other Studies

1 other study(ies) available for Brilliant Blue and Vascular Injuries

Article	Year
Brilliant blue FCF is a nontoxic dye for saphenous vein graft marking that abrogates response to injury. Journal of vascular surgery, 2016, Volume: 64, Issue:1 Topics: Animals; Aorta; Benzenesulfonates; Calcium Signaling; Cells, Cultured; Coloring Agents; Cytoprotection; Female; Human Umbilical Vein Endothelial Cells; Humans; Hyperplasia; In Vitro Techniques; Male; Neointima; Organ Culture Techniques; Purinergic P2X Receptor Antagonists; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Saphenous Vein; Swine; Vascular Grafting; Vascular System Injuries; Vasoconstriction	2016

Article

Year

Brilliant blue FCF is a nontoxic dye for saphenous vein graft marking that abrogates response to injury.

Journal of vascular surgery, 2016, Volume: 64, Issue:1

Topics: Animals; Aorta; Benzenesulfonates; Calcium Signaling; Cells, Cultured; Coloring Agents; Cytoprotection; Female; Human Umbilical Vein Endothelial Cells; Humans; Hyperplasia; In Vitro Techniques; Male; Neointima; Organ Culture Techniques; Purinergic P2X Receptor Antagonists; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Saphenous Vein; Swine; Vascular Grafting; Vascular System Injuries; Vasoconstriction

2016